Merck & CompanyvsSpyGlass Pharma

MRK and SGP stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$133.72

Value $331B

+0.69%
MRK's page

SGP

SpyGlass Pharma, Inc.

$30.43

Value $1.0B

-1.14%
SGP's page

Merck & Company (MRK) has a market value of $331B and SpyGlass Pharma (SGP) $1.0B. Dividend yield: MRK 2.54%, SGP none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$331B

    SGP$1.0B

    MRK is 325 times SGP

  • Revenue, 12 months

    MRK$67.4B

    SGP–

  • Net income, 12 months

    MRK$2.5B

    SGP-$70M

  • Operating margin

    MRK–

    SGP–

  • ROIC

    MRK3.9%

    SGP–

  • P/E

    MRK134.8

    SGP–

  • Dividend yield

    MRK2.5%

    SGP0.0%

    2.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+11.9%

SGP+15.3%

75100125

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanySGPSpyGlass Pharma

Valuation

MRKSGP
Valuation
Price$133.72$30.43
Market value$331B$1.0B
Enterprise value (EV)$375B$810M
P/E134.8–
P/E, 5-year median14.8–
P/B7.44.8
EV/EBIT78.7–
Free cash flow yield4.5%–

Results and growth

MRKSGP
Results and growth
Revenue, 12 months$67.4B–
Net income, 12 months$2.5B-$70M
Free cash flow, 12 months$14.7B-$59M
Earnings per share, 12 months$0.98-$7.71
Revenue growth, year on year1.3%–
Revenue growth a year, past+9.4%over 5 years–
EPS growth a year, past+21.2%over 5 years–

Margins and returns on capital

MRKSGP
Margins and returns on capital
Gross margin71.8%–
Operating margin––
Net margin3.6%–
ROIC3.9%–
ROE5.2%-69.5%

Balance sheet

MRKSGP
Balance sheet
Cash$9.7B$209M
Total debt$53.8B$1.6M
Net debt / EBITDA5.7–
Interest cover2.4×–

Dividends and buybacks

MRKSGP
Dividends and buybacks
Dividend yield2.5%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.5%0.1%
Shareholder yield4.1%0.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or SGP

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or SpyGlass Pharma?

By market value, Merck & Company ($331B) is about 324.7 times SpyGlass Pharma ($1.0B), at today's prices.

Which pays the higher dividend, MRK or SGP?

The dividend yield at today's price is 2.54% for Merck & Company and none for SpyGlass Pharma. Over the last twelve months they paid $3.40 and – per share.

Which is the better investment, Merck & Company or SpyGlass Pharma?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.